Silo Pharma, Inc. (SILO)

Silo Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	0.07	0.07	0.07	0	0.04
Revenue Growth (YoY)	0%	1.18%	-	-	-
Cost of Revenue	0.01	0.01	0.01	0	0.03
Gross Profit	0.07	0.07	0.07	0	0.01
Selling, General & Admin	1.26	0.8	0.56	0.81	0.41
Research & Development	0.85	1.29	0.69	0.03	0.06
Other Operating Expenses	1.82	1.6	1.56	1.37	0.47
Operating Expenses	3.92	3.69	2.81	2.2	0.94
Operating Income	-3.86	-3.63	-2.74	-2.2	-0.93
Interest Expense / Income	0	0	0	0.27	0.06
Other Expense / Income	-0.16	0.28	-6.68	0.57	0.02
Pretax Income	-3.7	-3.91	3.93	-3.04	-1.01
Income Tax	0	0	0.02	0	0
Net Income	-3.7	-3.91	3.9	-3.04	-1.01
Preferred Dividends	0	0	1.4	0.07	0
Net Income Common	-3.7	-3.91	2.5	-3.11	-1.01
Shares Outstanding (Basic)	3	2	2	1	0
Shares Outstanding (Diluted)	3	2	2	1	0
Shares Change	34.83%	19.07%	45.44%	181.04%	-52.20%
EPS (Basic)	-1.20	-1.71	1.32	-3.00	-2.00
EPS (Diluted)	-1.20	-1.71	1.30	-3.00	-2.00
Free Cash Flow	-3.22	-3.5	-2.28	-1.16	-0.79
Free Cash Flow Per Share	-1.05	-1.53	-1.20	-0.88	-1.69
Gross Margin	91.90%	91.90%	92.98%	-	32.49%
Operating Margin	-5347.41%	-5031.28%	-3850.95%	-	-2293.38%
Profit Margin	-5132.57%	-5420.86%	3507.72%	-	-2497.71%
Free Cash Flow Margin	-4472.13%	-4850.94%	-3196.59%	-	-1957.96%
Effective Tax Rate	-	-	0.63%	-	-
EBITDA	-3.7	-3.91	3.93	-2.77	-0.95
EBITDA Margin	-5125.81%	-5417.81%	5517.03%	-	-2342.59%
EBIT	-3.7	-3.91	3.93	-2.77	-0.95
EBIT Margin	-5125.81%	-5417.81%	5517.03%	-	-2342.59%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).